We automate
scientific analysis.
Make your labs fast and accurate with AI that learns from just a few examples.
Two events this week.
Two ways to connect.
Meet Lalin Theverapperuma, Ph.D., Founder and CEO of Expert Intelligence, on the first day of PharmSci 360, or join his talk on day two of AIDDD.
PharmSci 360
October 26 to 28, 2026 · New Orleans, LA
Meet the EI team to discuss your lab’s analytical workflows. Lalin will be at PharmSci 360 on the first day only, meeting with pharma leaders.
AI Drug Discovery & Development Summit
October 27 to 29, 2026 · Boston, MA
Come see Lalin on the second day of AIDDD for his talk:
The Next Frontier in Pharma AI:
Scaling Wet-Lab Throughput
Day 2, Wednesday, October 28 | 9:30 a.m. ET
Tech Ops Stage/Dartmouth & Exeter (Level 3)
Limited Sample Model
The only AI learning system that can learn from a small amount of data and deliver high accuracy for regulatory-grade scientific analysis.
Review the Exceptions.
Not the Whole Batch.
50×
Workflow Capacity
Raw instrument data to signed, LIMS-ready output across every method and site.
Analyst-Validated,
Production-Proven.
99.9%
Accuracy
Exception-based review with full traceability
eliminates manual decision drift.
Consistent Analysis.
Run After Run.
7×
Fewer Reruns
One platform across fragmented instruments, software, and data.
Move at the Speed of Discovery.
Trust Every Result.
AI has made the front of drug development faster than ever. Validating those candidates hasn't kept up. Analytical decisions are still made by hand and siloed by stage, so the pipeline moves at the speed of its slowest handoff.
Expert Intelligence scales and accelerates every analytical decision with regulatory-grade accuracy, connects them from discovery to manufacturing, and flags risk before it reaches release. Your programs move faster, and every result holds up.
One Platform. Every Instrument.
EI works across your existing instruments, methods, and sites, no rip-and-replace, with standard connectors into your LIMS and enterprise systems. Every result is confidence-calibrated, exception-routed, and regulatory-grade, with full traceability from raw data to signed output.
Your Data Stays Yours
EI deploys into your own environment, cloud, on-premises, or hybrid, so your data never leaves the place it was generated. No new hardware, validated configurations supported, nothing to rip out and replace.
Trained on Your Data. Owned by You.
Your scientists train the model inside your environment, no code required. About 50 examples is enough for it to learn your targets and your decision logic. From there, every analyst correction feeds back through active learning, refining it toward 99.9% accuracy, and the trained model is your institutional IP.
The methods your labs already run, automated.
EI Flow automates the review across all of them, turning raw instrument data into a SOP-aware, signed, explainable result. Your acceptance criteria, your method, your sign-off, on every one.
HPLC / UPLC
Release, purity, potency, and stability.
EI Flow handles peak review, integration, and specification checks across routine release and stability workflows, automatically clearing conforming results and surfacing new or growing degradants before they reach your queue.
GC-MS / HRMS
Impurity, residual, and identity confirmation.
EI Flow applies your validated acceptance criteria, clears conforming results for the report, and flags out-of-spec findings, closing the detect-to-identify loop with the traceability and consistency regulated workflows demand.
LC-MS / LC-MS/MS / MRM
Bioanalysis, identity, and quantitation.
Run acceptance, quantitation review, metabolite tracking, stability, and impurity monitoring across every injection, with your integration and acceptance decisions applied consistently at every site, including your CROs.
Intact Mass / ADC / AS-MS
Mass confirmation, proteoform, and DAR.
Deconvolution, proteoform analysis, DAR calculation, and microheterogeneity assessment, with consistent, signed interpretation that reads the same from lot to lot.
Titer / Potency / Binding Assays
Process, release, and development.
Automated curve fitting and endpoint determination where applicable, with assay acceptance across each method. Out-of-trend potency is flagged while final judgment on higher-variability functional assays stays with your experts.
Glycan Analysis
CMC, comparability, and characterization.
Isomer resolution, ambiguity management, and consistent annotation at scale, monitoring the critical glycan attributes that influence effector function, half-life, and immunogenicity across batches and sites.
iCIEF / CE / CE-SDS / SEC
Charge variant, size variant, and aggregation.
Peak identification, integration, and system suitability for biologics release, learning your charge and size calls to clear routine review, and pairing with EI Signal to catch aggregation trends across stability timepoints earlier.
Proteomics/ Biomarkers
Mechanism, translational, and clinical evidence.
Protein-, lipid-, and pathway-level confidence through alignment, interference control, and reproducible cross-batch identification, supporting the translational and clinical evidence your programs depend on.
See it in action.
Request a demo and see how trusted results compress the time and cost of drug development.
Privacy Policy | Terms & Conditions
Copyright © 2026 Tools for AI, Inc. All rights reserved